Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Liapakis

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Biomolecules|September 27, 2025
Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43Spyridon Marios Giatro, George Komontachakis, Aikaterini Kalantidou, et al.
Amino Acids|May 13, 2019
Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acidsVassiliki Magafa, Minos-Timotheos Matsoukas, Vlasios Karageorgos, et al.
Combinatorial Chemistry & High Throughput Screening|May 31, 2014
An efficient synthetic method and theoretical calculations of olmesartan methyl ether: study of biological function of AT1 antagonismDimitrios Ntountaniotis, George Agelis, Amalia Resvani, et al.
Bioorganic Chemistry|June 26, 2021
Synthesis, in vitro biological investigation, and molecular dynamics simulations of thiazolopyrimidine based compounds as corticotrophin releasing factor receptor-1 antagonistsHossam R Elgiushy, Nageh A Abou-Taleb, George G Holz, et al.
Combinatorial Chemistry & High Throughput Screening|March 10, 2015
Rational drug design paradigms: the odyssey for designing better drugsTahsin Kellici, Dimitrios Ntountaniotis, Eleni Vrontaki, et al.
Current Medicinal Chemistry|November 18, 2015
Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled ReceptorTahsin F Kellici, Dimitrios Ntountaniotis, Eftichia Kritsi, et al.
European Journal of Medicinal Chemistry|January 13, 2018
Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and imidazolone derivatives and analysis of their potential restrictive effects on cell proliferationSerdar Durdagi, Busecan Aksoydan, Ismail Erol, et al.
European Journal of Medicinal Chemistry|February 5, 2013
Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockersGeorge Agelis, Amalia Resvani, Catherine Koukoulitsa, et al.
Amino Acids|September 30, 2020
Discovery of a stable tripeptide targeting the N-domain of CRF1 receptorGeorge Liapakis, Vlasios Karageorgos, Ioannis Andreadelis, et al.
Molecular Pharmaceutics|January 26, 2019
Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II AntagonismDimitrios Ntountaniotis, Ioannis Andreadelis, Tahsin F Kellici, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Biomolecules|September 27, 2025
Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43Spyridon Marios Giatro, George Komontachakis, Aikaterini Kalantidou, et al.
Amino Acids|May 13, 2019
Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acidsVassiliki Magafa, Minos-Timotheos Matsoukas, Vlasios Karageorgos, et al.
Combinatorial Chemistry & High Throughput Screening|May 31, 2014
An efficient synthetic method and theoretical calculations of olmesartan methyl ether: study of biological function of AT1 antagonismDimitrios Ntountaniotis, George Agelis, Amalia Resvani, et al.
Bioorganic Chemistry|June 26, 2021
Synthesis, in vitro biological investigation, and molecular dynamics simulations of thiazolopyrimidine based compounds as corticotrophin releasing factor receptor-1 antagonistsHossam R Elgiushy, Nageh A Abou-Taleb, George G Holz, et al.
Combinatorial Chemistry & High Throughput Screening|March 10, 2015
Rational drug design paradigms: the odyssey for designing better drugsTahsin Kellici, Dimitrios Ntountaniotis, Eleni Vrontaki, et al.
Current Medicinal Chemistry|November 18, 2015
Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled ReceptorTahsin F Kellici, Dimitrios Ntountaniotis, Eftichia Kritsi, et al.
European Journal of Medicinal Chemistry|January 13, 2018
Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and imidazolone derivatives and analysis of their potential restrictive effects on cell proliferationSerdar Durdagi, Busecan Aksoydan, Ismail Erol, et al.
European Journal of Medicinal Chemistry|February 5, 2013
Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockersGeorge Agelis, Amalia Resvani, Catherine Koukoulitsa, et al.
Amino Acids|September 30, 2020
Discovery of a stable tripeptide targeting the N-domain of CRF1 receptorGeorge Liapakis, Vlasios Karageorgos, Ioannis Andreadelis, et al.
Molecular Pharmaceutics|January 26, 2019
Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II AntagonismDimitrios Ntountaniotis, Ioannis Andreadelis, Tahsin F Kellici, et al.
Pageof 5